Rhumbline Advisers Mckesson Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Mckesson Corp stock. As of the latest transaction made, Rhumbline Advisers holds 275,029 shares of MCK stock, worth $159 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

275,029

Previous 290,551 5.34%

Holding current value

$159 Million

Previous $170 Million 19.9%

% of portfolio

0.12%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$479.06 - $630.38 $7.44 Million - $9.78 Million	-15,522 Reduced 5.34%	275,029 $136 Million
Q2 2024 Aug 01, 2024	SELL	$518.81 - $607.81 $4.9 Million - $5.74 Million	-9,437 Reduced 3.15%	290,551 $170 Million
Q1 2024 May 09, 2024	BUY	$473.42 - $539.26 $8.56 Million - $9.75 Million	18,075 Added 6.41%	299,988 $161 Million
Q4 2023 Feb 08, 2024	SELL	$437.42 - $470.64 $5.03 Million - $5.41 Million	-11,504 Reduced 3.92%	281,913 $131 Million
Q3 2023 Nov 09, 2023	SELL	$402.4 - $446.42 $513,060 - $569,185	-1,275 Reduced 0.43%	293,417 $128 Million
Q2 2023 Aug 08, 2023	BUY	$354.01 - $427.31 $354 - $427	1 Added 0.0%	294,692 $126 Million
Q1 2023 May 11, 2023	SELL	$335.35 - $386.06 $5.82 Million - $6.7 Million	-17,344 Reduced 5.56%	294,691 $105 Million
Q4 2022 Feb 14, 2023	BUY	$346.68 - $397.58 $3.73 Million - $4.28 Million	10,762 Added 3.57%	312,035 $117 Million
Q3 2022 Nov 10, 2022	BUY	$321.25 - $373.84 $2.87 Million - $3.34 Million	8,927 Added 3.05%	301,273 $102 Million
Q2 2022 Aug 11, 2022	BUY	$300.57 - $336.42 $8.55 Million - $9.58 Million	28,462 Added 10.79%	292,346 $95.4 Million
Q1 2022 May 12, 2022	SELL	$244.61 - $310.48 $1.29 Million - $1.64 Million	-5,294 Reduced 1.97%	263,884 $80.8 Million
Q4 2021 Feb 10, 2022	SELL	$198.21 - $248.9 $1.5 Million - $1.88 Million	-7,546 Reduced 2.73%	269,178 $66.9 Million
Q3 2021 Nov 12, 2021	SELL	$188.42 - $208.66 $3.56 Million - $3.95 Million	-18,913 Reduced 6.4%	276,724 $55.2 Million
Q2 2021 Aug 05, 2021	SELL	$184.89 - $202.68 $5.03 Million - $5.52 Million	-27,223 Reduced 8.43%	295,637 $56.5 Million
Q1 2021 May 06, 2021	SELL	$169.52 - $196.53 $4.08 Million - $4.74 Million	-24,096 Reduced 6.94%	322,860 $63 Million
Q4 2020 Feb 10, 2021	SELL	$143.79 - $183.66 $1.7 Million - $2.17 Million	-11,819 Reduced 3.29%	346,956 $60.3 Million
Q3 2020 Nov 12, 2020	BUY	$140.89 - $159.9 $79,884 - $90,663	567 Added 0.16%	358,775 $53.4 Million
Q2 2020 Aug 13, 2020	BUY	$125.49 - $164.68 $3.03 Million - $3.98 Million	24,138 Added 7.23%	358,208 $55 Million
Q1 2020 May 06, 2020	BUY	$115.75 - $170.96 $38,313 - $56,587	331 Added 0.1%	334,070 $45.2 Million
Q4 2019 Feb 05, 2020	BUY	$130.23 - $153.27 $1.06 Million - $1.25 Million	8,127 Added 2.5%	333,739 $46.2 Million
Q3 2019 Oct 23, 2019	BUY	$134.24 - $148.53 $580,990 - $642,837	4,328 Added 1.35%	325,612 $44.5 Million
Q2 2019 Aug 14, 2019	SELL	$112.47 - $134.93 $4.22 Million - $5.07 Million	-37,561 Reduced 10.47%	321,284 $43.2 Million
Q1 2019 May 01, 2019	BUY	$111.86 - $136.3 $174,613 - $212,764	1,561 Added 0.44%	358,845 $42 Million
Q4 2018 Jan 31, 2019	BUY	$108.23 - $136.84 $898,850 - $1.14 Million	8,305 Added 2.38%	357,284 $39.5 Million
Q3 2018 Nov 07, 2018	SELL	$123.14 - $138.52 $5.05 Million - $5.68 Million	-41,028 Reduced 10.52%	348,979 $46.3 Million
Q2 2018 Aug 06, 2018	SELL	$133.4 - $158.13 $625,112 - $740,997	-4,686 Reduced 1.19%	390,007 $52 Million
Q1 2018 May 02, 2018	SELL	$138.75 - $176.72 $1.44 Million - $1.84 Million	-10,401 Reduced 2.57%	394,693 $55.6 Million
Q4 2017 Feb 09, 2018	BUY	$135.02 - $162.6 $727,622 - $876,251	5,389 Added 1.35%	405,094 $63.2 Million
Q3 2017 Nov 06, 2017	BUY	$146.0 - $161.87 $58.4 Million - $64.7 Million	399,705	399,705 $61.4 Million

Others Institutions Holding MCK

# of Institutions

1,690

Shares Held

108M

Call Options Held

1.66M

Put Options Held

968K

View Full List

About MCKESSON CORP

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $82.9B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

More about MCK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Mckesson Corp Transaction History